Stay updated on IPI-145 Plus FCR in CLL Clinical Trial

Sign up to get notified when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IPI-145 Plus FCR in CLL Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Massachusetts listed as a study site, and updated the page revision to v3.3.3. The old 'Massachusetts Locations' label was removed and the 'HHS Vulnerability Disclosure' footer link was also removed.
    Difference
    0.2%
    Check dated 2025-12-22T22:50:54.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The revision label on the page footer changed from v3.3.1 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-01T11:51:38.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.1, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:16:17.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Removed the government funding lapse and NIH operating status notice from the page.
    Difference
    0.4%
    Check dated 2025-11-17T06:11:37.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Updates appear to be minor UI/formatting adjustments to the Study Details page and do not modify core study information (eligibility criteria, outcomes, or trial status). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:49:32.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Update to v3.2.0 with a government-operating status notice; removal of a specific genetic disease resource (B-cell CLL).
    Difference
    4%
    Check dated 2025-10-05T06:41:19.000Z thumbnail image

Stay in the know with updates to IPI-145 Plus FCR in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.